← Open Payments lookup

PAULA SITU: Open Payments

NPI 1598703241 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,370 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $257 · 2025 $1,370

Food & beverage: $1,370
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$238
Edwards Lifesciences Corporation1$197
Dexcom, Inc.1$169
Madrigal Pharmaceuticals1$145
Alnylam Pharmaceuticals Inc.1$144
Insulet Corporation2$144
Novo Nordisk Inc1$124
GENZYME CORPORATION1$111
Novartis Pharmaceuticals Corporation1$98

Products named: SAPIEN 3 Ultra RESILIA, Dexcom G6 Transmitter, REZDIFFRA, ONPATTRO, Omnipod, UZEDY, Ozempic, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.